[go: up one dir, main page]

FR2899464B1 - Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee - Google Patents

Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee

Info

Publication number
FR2899464B1
FR2899464B1 FR0651255A FR0651255A FR2899464B1 FR 2899464 B1 FR2899464 B1 FR 2899464B1 FR 0651255 A FR0651255 A FR 0651255A FR 0651255 A FR0651255 A FR 0651255A FR 2899464 B1 FR2899464 B1 FR 2899464B1
Authority
FR
France
Prior art keywords
activator
regulator
glycoside compound
cutaneous immunity
cutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0651255A
Other languages
English (en)
Other versions
FR2899464A1 (fr
Inventor
Alexandre Cavezza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0651255A priority Critical patent/FR2899464B1/fr
Publication of FR2899464A1 publication Critical patent/FR2899464A1/fr
Application granted granted Critical
Publication of FR2899464B1 publication Critical patent/FR2899464B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0651255A 2006-04-07 2006-04-07 Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee Expired - Fee Related FR2899464B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0651255A FR2899464B1 (fr) 2006-04-07 2006-04-07 Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0651255A FR2899464B1 (fr) 2006-04-07 2006-04-07 Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee

Publications (2)

Publication Number Publication Date
FR2899464A1 FR2899464A1 (fr) 2007-10-12
FR2899464B1 true FR2899464B1 (fr) 2008-06-06

Family

ID=37461575

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0651255A Expired - Fee Related FR2899464B1 (fr) 2006-04-07 2006-04-07 Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee

Country Status (1)

Country Link
FR (1) FR2899464B1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100528128C (zh) 2004-03-08 2009-08-19 荷兰联合利华有限公司 含有糖内酯的头发处理组合物
WO2008110399A1 (fr) 2007-03-14 2008-09-18 Unilever Plc Procédé de traitement capillaire à base d'une composition sucrée
WO2008149022A2 (fr) * 2007-05-18 2008-12-11 L'oreal Utilisation de c-glycopeptides gem-difluores pour favoriser la pigmentation des matieres keratiniques
EP2194961B1 (fr) 2007-10-10 2011-08-03 Unilever PLC Procédé de traitement des cheveux
JP5647598B2 (ja) * 2008-03-28 2015-01-07 ユニリーバー・ナームローゼ・ベンノートシヤープ ヘアスタイリング組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614615A (en) * 1995-03-21 1997-03-25 The Scripps Research Institute Sialyl Lewis X mimetics incorporating fucopeptides
FR2750864B1 (fr) * 1996-07-10 1999-04-16 Oreal Utilisation d'un polyholoside dans une composition destinee a stimuler les defenses immunitaires, et composition le comprenant
FR2770776B1 (fr) * 1997-11-07 2000-03-17 Lvmh Rech Utilisations du d-xylose et de ses esters pour ameliorer la fonctionnalite des cellules de l'epiderme
FR2818646B1 (fr) * 2000-12-22 2006-06-23 Oreal Nouveaux derives c-glycoside et utilisation
CA2493690C (fr) * 2002-06-13 2011-11-08 New York University C-glycolipide de synthese et utilisation de celui-ci pour le traitement du cancer, des maladies infectieuses et des maladies auto-immunes

Also Published As

Publication number Publication date
FR2899464A1 (fr) 2007-10-12

Similar Documents

Publication Publication Date Title
EP2050749A4 (fr) Derive de pyrimidine comme inhibiteur de la pi3k et son utilisation
EP2084139A4 (fr) Composés d'oxazolidinium et utilisation en tant qu'inhibiteurs d'hydrate
EP2013701A4 (fr) Désambiguïsation d'entités nommées
DK1653807T3 (da) Anvendelse af dermale mikroorganer
EP2087435A4 (fr) Invocation de services d'application
EP2038252A4 (fr) Acylanilides substitués et procédés d'utilisation de ceux-ci
EP2054049A4 (fr) Acylanilides substitués et procédés d'utilisation de ceux-ci
EP2004246A4 (fr) Pansements dotés d'agents antimicrobien et contenant du zinc
EP2187742A4 (fr) Dérivés de benzylbenzène et procédés d'utilisation
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
IL197161A (en) Derivatives 4- (n-azacycloalkyl) anilides Preparations containing and using them
EP2081964A4 (fr) Compositions d'alginate et d'alginate-lyase et procédés d'utilisation
EP1762234A4 (fr) Activateur d'ampk
EP2297585A4 (fr) Détection de l' usage de cannabis
CY1113102T1 (el) Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων
FR2958542B1 (fr) Utilisation cosmetique de l'oridonine comme agent amincissant
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
EP2046128A4 (fr) Composition herbicide et son procédé d'utilisation
EP2376101A4 (fr) EFFECTEURS DE LA ß-ARRESTINE, COMPOSITIONS EN CONTENANT ET LEURS PROCÉDÉS D'UTILISATION
EP2037944A4 (fr) Étalon de tacrolimus et ses procédés d'utilisation
EP1701948A4 (fr) Essai d'entactogenes
FR2899464B1 (fr) Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee
DE602006011790D1 (de) Lösungsmittelfreie formulierung von triclopyr-butoxyethylester
FR2899588B1 (fr) Utilisation de compose c-glycoside derive de galactose comme agent activateur et regulateur de l'immunite cutanee
EP1837382A4 (fr) Composition d'agent de revetement et utilisation de la composition

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091231